New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A5200 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	ASSEMBLY, No. 5200 STATE OF NEW JERSEY 220th LEGISLATURE INTRODUCED FEBRUARY 16, 2023
2	2
3	3	ASSEMBLY, No. 5200
4	4
5	5
6	6
7	7	STATE OF NEW JERSEY
8	8
9	9	220th LEGISLATURE
10	10
11	11
12	12
13	13	INTRODUCED FEBRUARY 16, 2023
14	14
15	15
16	16
17	17	Sponsored by: Assemblywoman CAROL A. MURPHY District 7 (Burlington) Assemblyman JOHN F. MCKEON District 27 (Essex and Morris) Assemblywoman SHANIQUE SPEIGHT District 29 (Essex) SYNOPSIS Requires health insurance coverage of prescribed anti-obesity medication. CURRENT VERSION OF TEXT As introduced.
18	18
19	19
20	20
21	21	Sponsored by:
22	22
23	23	Assemblywoman CAROL A. MURPHY
24	24
25	25	District 7 (Burlington)
26	26
27	27	Assemblyman JOHN F. MCKEON
28	28
29	29	District 27 (Essex and Morris)
30	30
31	31	Assemblywoman SHANIQUE SPEIGHT
32	32
33	33	District 29 (Essex)
34	34
35	35
36	36
37	37
38	38
39	39
40	40
41	41
42	42
43	43	SYNOPSIS
44	44
45	45	Requires health insurance coverage of prescribed anti-obesity medication.
46	46
47	47
48	48
49	49	CURRENT VERSION OF TEXT
50	50
51	51	As introduced.
52	52
53	53
54	54
55	55	An Act concerning health insurance coverage for certain anti-obesity medication and supplementing various parts of the statutory law. Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1. a. A hospital service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the contract. c. The provisions of this section shall apply to all hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 2. a. Every medical service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74 (C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the contract. c. The provisions of this section shall apply to all medical service corporation contracts in which the medical service corporation has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 3. a. Every health service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1985, c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the contract. c. The provisions of this section shall apply to all health service corporation contracts in which the health service corporation has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 4. a. Every individual policy that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S. 17B:26-1 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named insured or other person covered thereunder for expenses incurred obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the policy. c. The provisions of this section shall apply to all health insurance policies in which the insurer has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 5. a. Every group policy that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named insured or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the policy. c. The provisions of this section shall apply to all health insurance policies in which the insurer has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 6. a. Every enrollee agreement that provides hospital or medical expense benefits and is delivered, issued, executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide health care services to any enrollee or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The health care services shall be provided to the same extent as for any other medical condition under the enrollee agreement. c. The provisions of this section shall apply to all enrollee agreements in which the health maintenance organization has reserved the right to change the schedule of charges. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 7. a. Every individual health benefits plan that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal in this State on or after the effective date of this act, shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the health benefits plan. c. The provisions of this section shall apply to all individual health benefits plans in which the carrier has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 8. a. Every small employer health benefits plan that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State on or after the effective date of this act, shall provide benefits to any person covered thereunder for expenses incurred obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the health benefits plan. c. The provisions of this section shall apply to all small business health benefits plans in which the carrier has reserved the right to change the premium. d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 9. a. The State Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act, that provides hospital or medical expense benefits shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the contract. c. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 10. a. The School Employees' Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital or medical expense benefits shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication. b. The benefits shall be provided to the same extent as for any other medical condition under the contract. c. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity. 11. This act shall take effect on the 90th day next following enactment and shall apply to policies and contracts that are delivered, issued, executed, or renewed on or after that date. STATEMENT This bill requires health insurance coverage of prescribed anti-obesity medication. Specifically, under the bill, health insurance carriers (including insurance companies, hospital service corporations, medical service corporations, health service corporations, health maintenance organizations authorized to issue health benefits plans in New Jersey, and any entities contracted to administer health benefits in connection with the State Health Benefits Program and School Employees' Health Benefits Program) will be required to cover prescribed anti-obesity medication that is approved by the U.S. Food and Drug Administration. It is the intent of the sponsor of this bill that access to obesity medication be expanded and that greater attention be placed on obesity as a disease. Since 2013, the American Medical Association has recognized obesity as a disease requiring treatment and prevention efforts. According to the World Health Organization, obesity leads to a range of non-communicable diseases such as type 2 diabetes, cardiovascular disease, hypertension, stroke, various forms of cancer, and various mental health issues. It is estimated that almost one-third of American adults and 17% of American children ages two to 19 are obese. Globally, more than one billion people are considered to be obese, with an additional 167 million people expected to become obese by 2025. By expanding access to FDA-approved anti-obesity medication such as "Wegovy," more individuals will be able to affordably access this effective treatment.
56	56
57	57	An Act concerning health insurance coverage for certain anti-obesity medication and supplementing various parts of the statutory law.
58	58
59	59
60	60
61	61	Be It Enacted by the Senate and General Assembly of the State of New Jersey:
62	62
63	63
64	64
65	65	1. a. A hospital service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1938, c.366 (C.17:48-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
66	66
67	67	b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
68	68
69	69	c. The provisions of this section shall apply to all hospital service corporation contracts in which the hospital service corporation has reserved the right to change the premium.
70	70
71	71	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
72	72
73	73
74	74
75	75	2. a. Every medical service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1940, c.74 (C.17:48A-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
76	76
77	77	b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
78	78
79	79	c. The provisions of this section shall apply to all medical service corporation contracts in which the medical service corporation has reserved the right to change the premium.
80	80
81	81	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
82	82
83	83
84	84
85	85	3. a. Every health service corporation contract that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1985, c.236 (C.17:48E-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named subscriber or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
86	86
87	87	b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
88	88
89	89	c. The provisions of this section shall apply to all health service corporation contracts in which the health service corporation has reserved the right to change the premium.
90	90
91	91	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
92	92
93	93
94	94
95	95	4. a. Every individual policy that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S. 17B:26-1 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named insured or other person covered thereunder for expenses incurred obtaining prescribed anti-obesity medication.
96	96
97	97	b. The benefits shall be provided to the same extent as for any other medical condition under the policy.
98	98
99	99	c. The provisions of this section shall apply to all health insurance policies in which the insurer has reserved the right to change the premium.
100	100
101	101	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
102	102
103	103
104	104
105	105	5. a. Every group policy that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to N.J.S.17B:27-26 et seq., or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide benefits to any named insured or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
106	106
107	107	b. The benefits shall be provided to the same extent as for any other medical condition under the policy.
108	108
109	109	c. The provisions of this section shall apply to all health insurance policies in which the insurer has reserved the right to change the premium.
110	110
111	111	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
112	112
113	113
114	114
115	115	6. a. Every enrollee agreement that provides hospital or medical expense benefits and is delivered, issued, executed, or renewed in this State pursuant to P.L.1973, c.337 (C.26:2J-1 et seq.), or approved for issuance or renewal in this State by the Commissioner of Banking and Insurance on or after the effective date of this act, shall provide health care services to any enrollee or other person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
116	116
117	117	b. The health care services shall be provided to the same extent as for any other medical condition under the enrollee agreement.
118	118
119	119	c. The provisions of this section shall apply to all enrollee agreements in which the health maintenance organization has reserved the right to change the schedule of charges.
120	120
121	121	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
122	122
123	123
124	124
125	125	7. a. Every individual health benefits plan that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.), or approved for issuance or renewal in this State on or after the effective date of this act, shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
126	126
127	127	b. The benefits shall be provided to the same extent as for any other medical condition under the health benefits plan.
128	128
129	129	c. The provisions of this section shall apply to all individual health benefits plans in which the carrier has reserved the right to change the premium.
130	130
131	131	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
132	132
133	133
134	134
135	135	8. a. Every small employer health benefits plan that provides hospital or medical expense benefits and is delivered, issued, executed or renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.), or approved for issuance or renewal in this State on or after the effective date of this act, shall provide benefits to any person covered thereunder for expenses incurred obtaining prescribed anti-obesity medication.
136	136
137	137	b. The benefits shall be provided to the same extent as for any other medical condition under the health benefits plan.
138	138
139	139	c. The provisions of this section shall apply to all small business health benefits plans in which the carrier has reserved the right to change the premium.
140	140
141	141	d. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
142	142
143	143	9. a. The State Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act, that provides hospital or medical expense benefits shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
144	144
145	145	b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
146	146
147	147	c. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
148	148
149	149
150	150
151	151	10. a. The School Employees' Health Benefits Commission shall ensure that every contract purchased by the commission on or after the effective date of this act that provides hospital or medical expense benefits shall provide benefits to any person covered thereunder for expenses incurred in obtaining prescribed anti-obesity medication.
152	152
153	153	b. The benefits shall be provided to the same extent as for any other medical condition under the contract.
154	154
155	155	c. For the purpose of this section, "anti-obesity medication" means any medication approved by the United States Food and Drug Administration that provides for chronic weight management in patients with obesity.
156	156
157	157
158	158
159	159	11. This act shall take effect on the 90th day next following enactment and shall apply to policies and contracts that are delivered, issued, executed, or renewed on or after that date.
160	160
161	161
162	162
163	163
164	164
165	165	STATEMENT
166	166
167	167
168	168
169	169	This bill requires health insurance coverage of prescribed anti-obesity medication.
170	170
171	171	Specifically, under the bill, health insurance carriers (including insurance companies, hospital service corporations, medical service corporations, health service corporations, health maintenance organizations authorized to issue health benefits plans in New Jersey, and any entities contracted to administer health benefits in connection with the State Health Benefits Program and School Employees' Health Benefits Program) will be required to cover prescribed anti-obesity medication that is approved by the U.S. Food and Drug Administration.
172	172
173	173	It is the intent of the sponsor of this bill that access to obesity medication be expanded and that greater attention be placed on obesity as a disease. Since 2013, the American Medical Association has recognized obesity as a disease requiring treatment and prevention efforts. According to the World Health Organization, obesity leads to a range of non-communicable diseases such as type 2 diabetes, cardiovascular disease, hypertension, stroke, various forms of cancer, and various mental health issues. It is estimated that almost one-third of American adults and 17% of American children ages two to 19 are obese. Globally, more than one billion people are considered to be obese, with an additional 167 million people expected to become obese by 2025. By expanding access to FDA-approved anti-obesity medication such as "Wegovy," more individuals will be able to affordably access this effective treatment.